Daniel R. Altmann

9.9k total citations · 3 hit papers
88 papers, 6.9k citations indexed

About

Daniel R. Altmann is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Rheumatology. According to data from OpenAlex, Daniel R. Altmann has authored 88 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Pathology and Forensic Medicine, 35 papers in Radiology, Nuclear Medicine and Imaging and 27 papers in Rheumatology. Recurrent topics in Daniel R. Altmann's work include Multiple Sclerosis Research Studies (61 papers), Advanced Neuroimaging Techniques and Applications (25 papers) and Systemic Lupus Erythematosus Research (18 papers). Daniel R. Altmann is often cited by papers focused on Multiple Sclerosis Research Studies (61 papers), Advanced Neuroimaging Techniques and Applications (25 papers) and Systemic Lupus Erythematosus Research (18 papers). Daniel R. Altmann collaborates with scholars based in United Kingdom, Italy and Spain. Daniel R. Altmann's co-authors include David H. Miller, Alan J. Thompson, Klaus Schmierer, Gareth J. Barker, Francesco Scaravilli, Katherine Miszkiel, Leonora Fisniku, Claudia A. M. Gandini Wheeler‐Kingshott, Paul S. Tofts and Patricio G. Schlottmann and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and NeuroImage.

In The Last Decade

Daniel R. Altmann

88 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

2008 649 citations Leonora Fisniku, P A Brex et al. Brain profile →
Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain

2004 608 citations Klaus Schmierer, Daniel R. Altmann et al. Annals of Neurology profile →
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

2012 457 citations Peter Connick, Daniel R. Altmann et al. The Lancet Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel R. Altmann United Kingdom	40	4.3k	2.0k	1.5k	1.4k	927	88	6.9k
Nikos Evangelou United Kingdom	37	4.3k 1.0×	1.4k 0.7×	1.8k 1.2×	1.1k 0.8×	819 0.9×	127	5.7k
Jens Wuerfel Germany	46	2.9k 0.7×	1.7k 0.9×	1.7k 1.1×	779 0.6×	779 0.8×	143	6.3k
Jaume Sastre‐Garriga Spain	45	5.3k 1.2×	1.0k 0.5×	2.3k 1.6×	1.7k 1.3×	809 0.9×	169	6.8k
Michael G. Dwyer United States	50	5.2k 1.2×	1.8k 0.9×	2.6k 1.7×	1.4k 1.0×	870 0.9×	285	7.8k
Brenda Banwell Canada	14	7.0k 1.6×	735 0.4×	2.5k 1.7×	1.7k 1.3×	1.1k 1.2×	30	8.6k
Niels Bergsland United States	46	4.6k 1.1×	1.7k 0.9×	2.2k 1.5×	1.3k 0.9×	1.0k 1.1×	315	7.0k
M. Clanet France	21	7.1k 1.6×	775 0.4×	2.7k 1.9×	1.7k 1.3×	1.1k 1.2×	49	9.2k
Angelo Ghezzi Italy	52	8.2k 1.9×	1.3k 0.7×	3.6k 2.4×	2.0k 1.5×	961 1.0×	219	10.1k
Declan Chard United Kingdom	45	5.1k 1.2×	2.4k 1.2×	1.7k 1.2×	1.5k 1.1×	879 0.9×	149	6.9k
Jack H. Simon United States	44	8.7k 2.0×	1.7k 0.9×	4.6k 3.1×	2.9k 2.2×	1.3k 1.4×	114	11.4k

Countries citing papers authored by Daniel R. Altmann

Since Specialization

Citations

This map shows the geographic impact of Daniel R. Altmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Altmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Altmann more than expected).

Fields of papers citing papers by Daniel R. Altmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Altmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Altmann. The network helps show where Daniel R. Altmann may publish in the future.

Co-authorship network of co-authors of Daniel R. Altmann

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Altmann. A scholar is included among the top collaborators of Daniel R. Altmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Altmann. Daniel R. Altmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brown, J William L, Ferrán Prados, Daniel R. Altmann, et al.. (2022). Remyelination varies between and within lesions in multiple sclerosis following bexarotene. Annals of Clinical and Translational Neurology. 9(10). 1626–1642. 14 indexed citations

Gold, Julian, Mónica Marta, Ute‐Christiane Meier, et al.. (2018). A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study. Multiple Sclerosis and Related Disorders. 24. 123–128. 26 indexed citations

Meier, Ute‐Christiane, Tove Christensen, Daniel R. Altmann, et al.. (2016). Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study biomarker outcome results. UCL Discovery (University College London). 1 indexed citations

Yiannakas, Marios, Francesco Grussu, Ferrán Prados, et al.. (2016). Reduced Field-of-View Diffusion-Weighted Imaging of the Lumbosacral Enlargement: A Pilot In Vivo Study of the Healthy Spinal Cord at 3T. PLoS ONE. 11(10). e0164890–e0164890. 11 indexed citations

Yiannakas, Marios, Ahmed M. Mustafa, Benjamin De Leener, et al.. (2015). Fully automated segmentation of the cervical cord from T1-weighted MRI using PropSeg: Application to multiple sclerosis. NeuroImage Clinical. 10. 71–77. 51 indexed citations

Pakpoor, Julia, Giulio Disanto, Daniel R. Altmann, et al.. (2015). Cancer Risk is Not Increased in People with Relapsing Multiple Sclerosis Taking Cladribine (P7.011). Neurology. 84(14_supplement). 1 indexed citations

Smith, Paul, Benjamin Turner, Daniel R. Altmann, et al.. (2015). FLAIR* for the non-invasive histological diagnosis of multiple sclerosis (S29.003). Neurology. 84(14_supplement). 2 indexed citations

Pardini, Matteo, Varun Sethi, Nils Muhlert, et al.. (2014). Network Efficiency As A Final Common Pathway For Cognitive Deficits In Multiple Sclerosis: A Single Network Graph Theory Study (P6.128). Neurology. 82(10_supplement). 2 indexed citations

Freund, Patrick, Nikolaus Weiskopf, John Ashburner, et al.. (2013). MRI investigation of the sensorimotor cortex and the corticospinal tract after acute spinal cord injury: a prospective longitudinal study. The Lancet Neurology. 12(9). 873–881. 212 indexed citations

10.

Henderson, Andrew, Daniel R. Altmann, S. Anand Trip, et al.. (2011). Early factors associated with axonal loss after optic neuritis. Annals of Neurology. 70(6). 955–963. 39 indexed citations

11.

Trip, S. Anand, Patricio G. Schlottmann, Constantinos Kallis, et al.. (2010). Scanning Laser Polarimetry Quantification of Retinal Nerve Fiber Layer Thinning Following Optic Neuritis. Journal of Neuro-Ophthalmology. 30(3). 235–242. 9 indexed citations

12.

Hayton, Thomas, J Furby, Kenneth J. Smith, et al.. (2009). Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis. Journal of Neurology. 256(3). 427–435. 23 indexed citations

13.

Caseiras, Gisele Brasil, Olga Ciccarelli, Daniel R. Altmann, et al.. (2009). Low-Grade Gliomas: Six-month Tumor Growth Predicts Patient Outcome Better than Admission Tumor Volume, Relative Cerebral Blood Volume, and Apparent Diffusion Coefficient. Radiology. 253(2). 505–512. 65 indexed citations

14.

Fisniku, Leonora, P A Brex, Daniel R. Altmann, et al.. (2008). Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 131(3). 808–817. 649 indexed citations breakdown →

15.

Fisniku, Leonora, Declan Chard, Jonathan S. Jackson, et al.. (2008). Gray matter atrophy is related to long‐term disability in multiple sclerosis. Annals of Neurology. 64(3). 247–254. 368 indexed citations

16.

Price, Gary, Mara Cercignani, Geoff J.M. Parker, et al.. (2007). White matter tracts in first-episode psychosis: A DTI tractography study of the uncinate fasciculus. NeuroImage. 39(3). 949–955. 96 indexed citations

17.

Trip, S. Anand, Patricio G. Schlottmann, Daniel R. Altmann, et al.. (2007). An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain. 131(Pt 1). 277–87. 185 indexed citations

18.

Swanton, Josephine, Àlex Rovira, Mar Tintoré, et al.. (2007). MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. The Lancet Neurology. 6(8). 677–686. 225 indexed citations

19.

Price, Gary, Mara Cercignani, Geoff J.M. Parker, et al.. (2006). Abnormal brain connectivity in first-episode psychosis: A diffusion MRI tractography study of the corpus callosum. NeuroImage. 35(2). 458–466. 101 indexed citations

20.

Davies, Gerard R., Daniel R. Altmann, Andreas Hadjiprocopis, et al.. (2005). Increasing normal–appearing grey and white matter magnetisation transfer ratio abnormality in early relapsing–remitting multiple sclerosis. Journal of Neurology. 252(9). 1037–1044. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact